Obesity  >>  Invokana (canagliflozin)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Invokana (canagliflozin) / J&J, Daiichi Sankyo, Mitsubishi Tanabe
NCT01756404: Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Otherwise Healthy Obese Volunteers

Completed
1
80
US
Canagliflozin (JNJ-28431754), JNJ-28431754, Placebo
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Healthy
12/07
12/07

Download Options